Price Move History
- Daily moves over 5%
- 9 13 sessions, July 10, 2025 to July 31, 2026
- Largest daily move
- +55.5% close of February 10, 2026
- 1-year change
- +125.4% closing prices, July 10, 2025 to July 31, 2026
- 1-month change
- +0.8% closing prices, June 25, 2026 to July 31, 2026
Company Description
POOLBEG PHARMA PLC (OTC: POLBF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $43.4M.
POLBF has gained 125.4% over the past year. The last closing price was $0.0958.
This page collects what Stock Titan holds for POLBF, including price data, latest news, and short interest trends.
Stock Performance
POOLBEG PHARMA PLC (POLBF) closed at $0.0958 on July 31, 2026. Over the past 12 months, the price has gained 125.4%.
POLBF Metrics & Rankings
Price returns through July 31, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
POOLBEG PHARMA PLC has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. Key topics include management, acquisition. View all POLBF news →
SEC Filings
Short Interest History
Short interest in POOLBEG PHARMA PLC (POLBF) currently stands at 5.0 thousand shares, representing 0.0% of the float. Since February 2026, short interest has increased by 150.0%.
Days to Cover History
Days to cover for POOLBEG PHARMA PLC (POLBF) currently stands at 1000.0 days, up 16566.5% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since February 2026, the figure has increased by 19899.8%. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
POLBF Company Profile & Sector Positioning
POOLBEG PHARMA PLC (POLBF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing POLBF often look at related companies in the same sector, including MINDMAZE THRAPEUTICS HLDS (RLFTF), MINDMAZE THERAPUTCS (RLFTY), COVALON TECHS LTD (CVALF), SERNOVA BIOTHERAPEUTICS (SEOVF), and ZIVO BIOSCIENCE INC (ZIVO). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate POLBF's relative position within its industry.